Table: Noile-Immune Biotech - 6-MTH parent results
Aug 10 (Reuters)-
Noile-Immune Biotech Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2023 Jun 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 11 mln 319 mln
(-49.0 pct)
Operating loss 481 mln loss 1.54
Recurring loss 832 mln loss 1.83
Net loss 833 mln loss 1.83
EPS loss 21.03 yen loss 44.27 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Noile-Immune Biotech Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T